Annual ROA
-116.06%
-42.71%-58.23%
December 31, 2023
Summary
- As of February 8, 2025, AVTX annual return on assets is -116.06%, with the most recent change of -42.71% (-58.23%) on December 31, 2023.
- During the last 3 years, AVTX annual ROA has risen by +42.96% (+27.02%).
- AVTX annual ROA is now -337.49% below its all-time high of 48.87%, reached on December 31, 2017.
Performance
AVTX ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-10.45%
+48.64%+82.32%
September 30, 2024
Summary
- As of February 8, 2025, AVTX quarterly return on assets is -10.45%, with the most recent change of +48.64% (+82.32%) on September 30, 2024.
- Over the past year, AVTX quarterly ROA has increased by +48.64% (+82.32%).
- AVTX quarterly ROA is now -108.34% below its all-time high of 125.30%, reached on September 30, 2017.
Performance
AVTX Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
AVTX ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -58.2% | +82.3% |
| 3 y3 years | +27.0% | +87.8% |
| 5 y5 years | -63.8% | +70.4% |
AVTX ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -58.2% | +14.7% | at high | +96.6% |
| 5 y | 5-year | -284.1% | +27.0% | at high | +96.6% |
| alltime | all time | -337.5% | +59.4% | -108.3% | +96.6% |
Avalo Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -10.45%(-82.3%) |
| Jun 2024 | - | -59.09%(-80.6%) |
| Mar 2024 | - | -304.70%(+178.4%) |
| Dec 2023 | -116.06%(+58.2%) | -109.45%(+5.3%) |
| Sep 2023 | - | -103.94%(+36.5%) |
| Jun 2023 | - | -76.16%(+3.2%) |
| Mar 2023 | - | -73.80%(-13.5%) |
| Dec 2022 | -73.35%(-46.1%) | -85.28%(+2.3%) |
| Sep 2022 | - | -83.34%(-22.3%) |
| Jun 2022 | - | -107.30%(+3.4%) |
| Mar 2022 | - | -103.79%(-14.7%) |
| Dec 2021 | -136.12%(-14.4%) | -121.67%(-1.9%) |
| Sep 2021 | - | -124.07%(-3.3%) |
| Jun 2021 | - | -128.33%(-1.8%) |
| Mar 2021 | - | -130.65%(+3.9%) |
| Dec 2020 | -159.02%(+426.2%) | -125.80%(+44.6%) |
| Sep 2020 | - | -86.97%(+25.9%) |
| Jun 2020 | - | -69.10%(+26.4%) |
| Mar 2020 | - | -54.68%(+102.8%) |
| Dec 2019 | -30.22% | -26.96%(-23.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | -35.28%(-46.2%) |
| Jun 2019 | - | -65.53%(+2.2%) |
| Mar 2019 | - | -64.11%(-1.3%) |
| Dec 2018 | -70.85%(-245.0%) | -64.98%(-8.0%) |
| Sep 2018 | - | -70.62%(-603.3%) |
| Jun 2018 | - | 14.03%(-58.8%) |
| Mar 2018 | - | 34.07%(-50.4%) |
| Dec 2017 | 48.87%(-117.1%) | 68.70%(-45.2%) |
| Sep 2017 | - | 125.30%(-182.6%) |
| Jun 2017 | - | -151.67%(-8.5%) |
| Mar 2017 | - | -165.72%(+14.3%) |
| Dec 2016 | -285.52%(+489.4%) | -144.96%(+20.3%) |
| Sep 2016 | - | -120.52%(+32.6%) |
| Jun 2016 | - | -90.92%(-5.3%) |
| Mar 2016 | - | -96.03%(+0.4%) |
| Dec 2015 | -48.44%(-62.8%) | -95.67%(-11.8%) |
| Sep 2015 | - | -108.51%(-27.6%) |
| Jun 2015 | - | -149.79%(+2.7%) |
| Mar 2015 | - | -145.81%(+11.9%) |
| Dec 2014 | -130.35%(-49.3%) | -130.35% |
| Dec 2013 | -257.01% | - |
FAQ
- What is Avalo Therapeutics annual return on assets?
- What is the all time high annual ROA for Avalo Therapeutics?
- What is Avalo Therapeutics annual ROA year-on-year change?
- What is Avalo Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Avalo Therapeutics?
- What is Avalo Therapeutics quarterly ROA year-on-year change?
What is Avalo Therapeutics annual return on assets?
The current annual ROA of AVTX is -116.06%
What is the all time high annual ROA for Avalo Therapeutics?
Avalo Therapeutics all-time high annual return on assets is 48.87%
What is Avalo Therapeutics annual ROA year-on-year change?
Over the past year, AVTX annual return on assets has changed by -42.71% (-58.23%)
What is Avalo Therapeutics quarterly return on assets?
The current quarterly ROA of AVTX is -10.45%
What is the all time high quarterly ROA for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly return on assets is 125.30%
What is Avalo Therapeutics quarterly ROA year-on-year change?
Over the past year, AVTX quarterly return on assets has changed by +48.64% (+82.32%)